Chrysos (ASX:C79) Loss Widening Tests Bullish Profitability And Growth Narratives

Chrysos (ASX:C79) has just posted its H1 2026 numbers, with the latest half-year profile shaped by prior period revenue of A$37.0 million and a basic EPS loss of A$0.0486, against a current share price of A$8.03. The company has seen revenue move from A$26.4 million in H2 2024 to A$29.1 million in H1 2025 and then A$37.0 million in H2 2025, while basic EPS shifted from a profit of A$0.0209 in H2 2024 to losses of A$0.0227 and A$0.0486 in the following halves, creating a picture in which top line expansion sits alongside compressed margins.

See our full analysis for Chrysos.

With the headline figures in place, the next step is to test how these results line up with the widely followed growth and risk narratives that investors have been using to frame Chrysos’s story.

See what the community is saying about Chrysos

Losses widen to A$8.2 million on A$66.1 million TTM revenue

• Over the trailing twelve months, Chrysos generated A$66.1 million of revenue and recorded a net loss of A$8.2 million, compared with half year figures that moved from a A$2.4 million profit in H2 2024 to losses of A$2.6 million and A$5.6 million in H1 and H2 2025.
• Analysts with a bullish view see these current losses as a staging point for much higher earnings, yet the A$8.2 million loss creates a clear test for those forecasts.
  • Bullish projections look for earnings to reach A$30.5 million by around 2028, starting from that A$8.2 million loss, which implies a very large swing in profitability that has not yet appeared in the historical half year data.
  • Supporters of the bullish case point to PhotonAssay rollout and margin potential, while the recent shift from a A$2.4 million profit to successive losses is a reminder that the current reported track record is still firmly in loss making territory.

Consistent losses at this scale are exactly what bullish investors are betting will flip, so it is worth checking how their full case hangs together in detail. 🐂 Chrysos Bull Case

Premium P/S of 14.1x against peers at 2.2x

• The shares trade on a P/S of 14.1x, compared with a peer average of 2.2x and an Australian Professional Services industry average of 1.5x, while the current price is A$8.03 against an analyst target of A$8.96.
• Skeptical investors argue that paying 14.1x sales for a business that is still loss making on A$66.1 million of trailing revenue leaves little room for disappointment.
  • The bearish narrative highlights that even on their own assumptions, earnings in 2028 would be A$13.4 million and the shares would need to trade on a P/E of 70.8x to support their A$6.5 target case, which underlines how stretched valuation multiples already look compared to the industry P/E of 19.1x mentioned in that view.
  • At the same time, the A$8.96 analyst target is only modestly above the current A$8.03 price, which in that framework indicates that a lot of the expected revenue and earnings growth is already reflected in today’s valuation.

If you want to see how the cautious case lines up these valuation hurdles with the current numbers, it is worth reading the full bear-side breakdown. 🐻 Chrysos Bear Case

High growth forecasts meet short cash runway

• Forecasts are calling for revenue growth of about 21% per year and earnings growth of 58.36% per year with profitability expected within three years, while the company is flagged as having less than one year of cash runway.
• What stands out is how sharply the consensus style growth story bumps up against the funding risk highlighted in the analysis.
  • On one side, the expectation of 21% annual revenue growth and a move from an A$8.2 million loss into profit suggests a business that many investors think can scale quickly from its A$66.1 million revenue base.
  • On the other, a cash runway of under a year means that any path to those earnings forecasts likely depends on either very strong cash generation soon or fresh capital, which matters given the current P/S of 14.1x and the premium already implied in the share price versus peers.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Chrysos on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Mixed messages in the story so far? If you want to move quickly and build your own view from the ground up, start by weighing up the balance of 1 key reward and 1 important warning sign.

Explore Alternatives

Chrysos is carrying ongoing losses on A$66.1 million of revenue, a rich 14.1x P/S multiple and less than one year of cash runway, which all raise clear risk questions.

If that mix of premium pricing and funding pressure makes you uneasy, you might want to shift your focus toward companies already passing our 6 resilient stocks with low risk scores and compare how a steadier profile feels.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com